SLRX
Salarius Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website alariuspharma.com
- Employees(FY) 12
- ISIN US79400X3052
Performance
-2.54%
1W
-1.1%
1M
-14.68%
3M
-28.34%
6M
-23.92%
YTD
-65.42%
1Y
Profile
Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. Salarius Pharmaceuticals, Inc. is headquartered in Houston, Texas.
Technical Analysis of SLRX 2024-05-10
Overview:
In analyzing the technical indicators for SLRX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key factors, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-13 10:53
- 2024-05-13 04:43
Salarius: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-03-22 09:52
- 2024-03-22 04:34
Salarius: Q4 Earnings Snapshot(Yahoo Finance)
- 2024-03-22 04:05
- 2024-02-21 19:00
- 2024-01-15 19:00
- 2024-01-02 19:30
- 2023-11-09 16:03
Salarius: Q3 Earnings Snapshot(Yahoo Finance)
- 2023-11-06 19:30
- 2023-08-10 05:10
Salarius: Q2 Earnings Snapshot(Yahoo Finance)
- 2023-08-10 04:05
- 2023-08-08 19:39
SLRX Pursuing Strategic Alternatives(Yahoo Finance)
- 2023-08-08 04:05
- 2023-07-10 21:00
SLRX Continues Cancer Fight with Phase I Trial Approval(Yahoo Finance)
- 2023-07-10 20:30
- 2023-06-11 20:00
- 2023-05-16 04:05
- 2023-05-11 20:00
- 2023-05-10 20:20
Salarius: Q1 Earnings Snapshot(Yahoo Finance)
- 2023-05-10 20:00
- 2023-05-08 20:00
- 2023-05-08 19:34
SLRX: Fighting Cancer Through Two Paths(Yahoo Finance)
- 2023-04-30 20:30
- 2023-04-19 20:30
- 2023-04-04 04:02
- 2023-04-04 00:00
- 2023-03-26 20:30
- 2023-03-14 23:00
- 2023-03-06 19:00
Page 1 of 4
previousnext